Results 61 to 70 of about 1,656 (147)

Randomized Phase 1 Studies Evaluating the Safety, Tolerability, Pharmacokinetics, and Target Occupancy of Zampilimab in Healthy Participants. [PDF]

open access: yesClin Pharmacol Drug Dev
Collier J   +10 more
europepmc   +1 more source

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases. [PDF]

open access: yesNephrol Dial Transplant
Apperloo EM   +3 more
europepmc   +1 more source

New Insights into Radical Mechanisms in Natural Drying Oils: Paint Binders as Reactors for Nanoparticle Formation. [PDF]

open access: yesACS Omega
de Viguerie L   +7 more
europepmc   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. [PDF]

open access: yesObesity (Silver Spring)
Bays HE   +9 more
europepmc   +1 more source

Pharmacologic treatment of obesity in adults: Standards of care in overweight and obesity. [PDF]

open access: yesBMJ Open Diabetes Res Care
American Diabetes Association Professional Practice Committee for Obesity.
europepmc   +1 more source

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials. [PDF]

open access: yesRheumatol Ther
Reveille JD   +11 more
europepmc   +1 more source

Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status. [PDF]

open access: yesKidney Int Rep
Correa-Rotter R   +14 more
europepmc   +1 more source

Clinical Benefits and Safety of Multiple Micronutrient Supplementation During Preconception, Pregnancy, and Lactation: A Review. [PDF]

open access: yesNutr Rev
Liu J   +8 more
europepmc   +1 more source

Characterization of insecticide resistance mechanisms in the Anopheles gambiae population of Sierra Leone. [PDF]

open access: yesMalar J
Opondo KO   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy